Antibodies directed against CD20 (L26, Leu 16, and Bl) are frequently used to determine the presence of B lymphocytes. However, recent publications describe the unexpected presence of CD20-positive T cells in the peripheral blood of normal subjects and occasional T-cell neoplasms that express CD20. To determine the presence of CD20-positive T cells in bone marrow, flow cytometric analysis was performed on 34 aspirate specimens (14 normal, 5 acute lymphoblastic lymphoma |ALL|, 5 acute myelogenous leukemia |AML|, 4 HIV positive, 2 myelodysplastic/myeloproliferative, 2 chronic myelogenous leukemia |CML|, 1 chronic lymphocytic lymphoma |CLL], 1 multiple myeloma). A small population of cells coexpressing CD3 (Leu 4) and CD20 dim (Leu 16) was identified in 94% of the specimens, representing 0% to 11%
Corporation [Hialeah, FL] ; and L26 from Dako [Santa Barbara, CA]. Therefore, this antigen is frequently used to designate B-cell lineage.
Recent studies question the diagnostic utility of the CD20 antigen. 6 " 8 Benign and neoplastic populations of T cells have been identified that also mark with the CD20 antigen. 6 
"
10 During a routine flow cytometric analysis of bone marrow specimens, several cases were identified in which the number of cells expressing CD20 exceeded the number of CD 19-positive cells. Therefore, a prospective evaluation of 34 bone marrow specimens was undertaken using multi-parameter flow cytometric analysis to identify T cells that coexpressed CD20.
MATERIALS AND METHODS
Consecutive, routinely submitted posterior iliac bone marrow aspirate specimens were collected and anticoagulated with EDTA. The specimens were processed within 24 hours of collection and analyzed by flow cytometry using direct immunofluorescence.
The bone marrow cells were separated by Ficoll gradient, red blood cells were lysed with ammonium chloride, and cells were resuspended in phosphate buffered saline containing fetal calf serum (Irvine Scientific, Santa Ana, CA) to inhibit nonspecific binding. The specimens were then incubated with monoclonal antibodies for 30 minutes at 4 °C, washed with phosphate buffered saline, and ALGINO ET AL. Data from a minimum of 10,000 events were collected list mode from cell suspensions labeled with two fluorescent markers using a FACScan (Becton Dickinson, San Jose, CA) flow cytometer. The data were analyzed using Simulset (Becton Dickinson) software. The lymphocyte gate was established using a combination of CD45/CD14 staining and light scatter characteristics." The samples were screened for viability using trypan blue exclusion (mean viability of gated cells 94.74 ± 5.55%, range 76%-100%). Isotype controls were used to discriminate positive staining such that <0.5% of the lymphocyte fluorescence was above or to the right of the cursor. Nonlymphoid cell contamination of the gated population was less than 5% of the gated events.
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CD20 Expression on T Cells
RESULTS
Two-color flow cytometric analysis of bone marrow aspirates from 34 consecutive routinely submitted specimens stained with anti-CD20 (Leu 16) and anti-CD3 (Leu4) revealed a small subset of T lymphocytes co-expressing CD20 antigen. This represented a mean percentage of 1.77 ± 2.36% (range 0.0%-11.0%) of the total marrow mononuclear cells and 6.54 ± 5.15% (range 0.0%-22.2%) of marrow lymphoid cells. CD20 expression on T cells was less intense than that seen on B cells. However, CD20 dim positive cells in the bone marrow also included CD3-negative immature B cells.
The samples containing CD20-positive T cells were obtained from 21 men and 13 women having a mean age of 52.2 ± 19.4 years (range 20-84 years). Diagnoses included acute lymphoblastic lymphoma (5), acute myelogenous leukemia (5), HIV infection (4), myelodysplastic/myeloproliferative disorder (2), chronic myelogenous leukemia (2), chronic lymphocytic lymphoma (1), multiple myeloma (1), and several cases studied for staging purposes which exhibited a normal cell composition (14) . Analysis revealed no correlation between the percentage of CD20-positive T lymphocytes and the CD4: CD8 ratio, patient age, gender, or diagnosis.
DISCUSSION
Analysis of 34 bone marrow specimens revealed 32 (94%) containing a subset of T lymphocytes expressing the CD20 antigen (Fig. 1 ). CD20 expression on T cells was of similar, dim intensity to that seen on immature B Previous immunophenotypic studies performed on peripheral blood have identified a similar population of circulating T cells coexpressing CD20. 6 ' 7 Hultin and colleagues originally described dim CD20 expression on CD3-positive T cells comprising 2.4 ± 1.5% of peripheral blood lymphocytes. 6 Blocking studies confirmed that the antibodies were specifically bound to the CD20 molecule. 6 The T-cell nature of the CD20 coexpressing cells was confirmed by induction of calcium influx after crosslinking the cell surface CD3 antigen. 6 Further three-color analysis of the CD20-positive circulating T cells revealed a resting mature T-cell phenotype: CD8+, CD45RO+, T-cell receptor y/8+, C D 3 8 -, C D 4 -, CD45RA-. 6 In addition, the T cells expressing CD20 expressed the pan-T-cell antigens CD2 and CD5. 6 7 Subsequently, Quinantilla-Martinez and colleagues 7 confirmed the presence of reactive circulating CD20-positive T cells ( Table 1.) Review of the literature also reveals several reports of neoplastic T cells expressing CD20 as determined by immunohistochemistry.
712 " 15 These reports include cases classified as pleomorphic medium and large cell lymphoma, immunoblastic lymphoma, anaplastic large cell lymphoma, acute lymphoblastic leukemia, and T-cell/ natural killer cell lymphoma (Table 2) . Although an additional study identified a high percentage of T-cell lymphomas exhibiting reactivity to the antibody L26, these cases exhibited reactivity of the endothelial cells, macrophages, and epithelial cells. 10 Subsequent review indicates there may have been nonspecific binding of the CD20 antibody. 9 Three cases of T-acute lymphoblastic leukemia and an unusual lymphoma exhibiting natural killer/T lymphocytic immunophenotype are the only cases reported to date on which CD20 expression was detected by flow cytometric analysis. 8 Studies also revealed the neoplastic populations exhibited several Tcell antigens including CD2, CD3, CD4, CD5 and CD7.
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The identification of CD20 antigen expression on T cells is reminiscent of the well-recognized normal B-cell subset expressing CD5 antigen. 1617 Initially, the CD5 expression on B cells was shown to identify and classify a subset of lymphoproliferative disorders (ie, chronic lymphocytic leukemia/small lymphocytic lymphoma [CLL/ SLL]). Subsequent studies revealed a normal B-cell population with the same phenotype.
17 CD5-positive B cells constitute a major B-cell subpopulation in fetal spleen and umbilical cord blood and a smaller subpopulation in adult peripheral blood, spleen, and lymph nodes. However, this population is generally not detectable in the bone marrow. 17 Circulating normal CD5 B cells are increased some disease processes, most notably in autoimmune disease. The purpose of CD20 expression on T cells is unknown. However, recognition of this distinct subset of T cells is essential when interpreting immunophenotypic analysis of peripheral blood and bone marrow specimens. This normal subset of T cells generally comprises a small subpopulation, whereas rare larger populations have been shown to represent neoplastic proliferations. However, it is important to recognize that not all CD20 d im cells present in the bone marrow are immature B cells, and that the presence of CD20 expression on Tcell proliferations does not necessarily indicate the presence of malignancy. Certain immunophenotypic panels and patterns may be helpful in delineating this T-cell population.
Expression of CD 19 on B-cells is highly conserved and is first identified before the expression of CD20. 4 5 A Tcell population exhibiting CD20 should be suspected if the CD20 population is greater than the CD 19 population. Diagnostic difficulties may be resolved by including CD3/CD20 in an analytic panel. High conservation of CD3 on T cells will help enumerate the CD20 dim T cells in the specimen. A T-cell population expressing CD20 may be further defined with either two-or three-color
